LinkedIn

 آمار

تعداد نشریات20
تعداد شماره‌ها1,113
تعداد مقالات10,208
تعداد مشاهده مقاله40,780,166
تعداد دریافت فایل اصل مقاله8,803,948
Negahdaripour, Manica. (1399). The Rise and Fall in Therapeutic Candidates for COVID-19. سامانه مدیریت نشریات علمی, 45(4), 231-232. doi: 10.30476/ijms.2020.46689
Manica Negahdaripour. "The Rise and Fall in Therapeutic Candidates for COVID-19". سامانه مدیریت نشریات علمی, 45, 4, 1399, 231-232. doi: 10.30476/ijms.2020.46689
Negahdaripour, Manica. (1399). 'The Rise and Fall in Therapeutic Candidates for COVID-19', سامانه مدیریت نشریات علمی, 45(4), pp. 231-232. doi: 10.30476/ijms.2020.46689
Negahdaripour, Manica. The Rise and Fall in Therapeutic Candidates for COVID-19. سامانه مدیریت نشریات علمی, 1399; 45(4): 231-232. doi: 10.30476/ijms.2020.46689

The Rise and Fall in Therapeutic Candidates for COVID-19

Iranian Journal of Medical Sciences
مقاله 1، دوره 45، شماره 4، مهر 2020، صفحه 231-232    اصل مقاله (149.21 K)
نوع مقاله: Editorial
شناسه دیجیتال (DOI): 10.30476/ijms.2020.46689
نویسنده
Manica Negahdaripour* 1، 2
1Pharmaceutical Sciences Research Center, Shiraz University of Medical Sciences, Shiraz, Iran
2Department of Pharmaceutical Biotechnology, School of Pharmacy, Shiraz University of Medical Sciences, Shiraz, Iran
چکیده
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), an RNA virus from the betacoronavirus genus, has caused a serious worldwide turmoil recently. Since the first report of this virus in China in Dec. 2019, several research fields were rapidly opened globally. Virus characterization led to the identification of its similarities with two other known deadly coronaviruses, SARS-CoV (with the highest nucleotide identity of 79.7%) and Middle East Respiratory Syndrome Coronavirus (MERS-CoV).1 Its pathogenesis is still one of the hot topics. The methods of viral transfection, epidemiology, and related subjects, have also been in focus to help in suggesting preventives strategies. The key issue of treating the infected patients is also one of the most investigated areas in parallel. Considering the urgency and importance of this subject, many drugs that were already approved or tested for other diseases were proposed to help patients at risk,2 some of which sooner or later were announced to be unworthy and dropped out of the list. 
کلیدواژه‌ها
COVID؛ 19
سایر فایل های مرتبط با مقاله
مراجع
  1. Zhou Y, Hou Y, Shen J, Huang Y, Martin W, Cheng F. Network-based drug repurposing for novel coronavirus 2019-nCoV/SARS-CoV-2. Cell Discov. 2020;6:14. doi: 10.1038/s41421-020-0153-3. PubMed PMID: 32194980; PubMed Central PMCID: PMCPMC7073332.
  2. Negahdaripour M. A World of Changes: The Inheritance of COVID-19. Iran J Med Sci. 2020;45:155-6. doi: 10.30476/ijms.2020.46530. PubMed PMID: 32546881; PubMed Central PMCID: PMCPMC7253492.
  3. Beigel JH, Tomashek KM, Dodd LE, Mehta AK, Zingman BS, Kalil AC, et al. Remdesivir for the Treatment of Covid-19 - Preliminary Report. N Engl J Med. 2020. doi: 10.1056/NEJMoa2007764. PubMed PMID: 32445440; PubMed Central PMCID: PMCPMC7262788.
  4. Ledford H. Coronavirus breakthrough: dexamethasone is first drug shown to save lives. Nature. 2020;582:469. doi: 10.1038/d41586-020-01824-5. PubMed PMID: 32546811.
  5. Hung IF, Lung KC, Tso EY, Liu R, Chung TW, Chu MY, et al. Triple combination of interferon beta-1b, lopinavir-ritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID-19: an open-label, randomised, phase 2 trial. Lancet. 2020;395:1695-704. doi: 10.1016/S0140-6736(20)31042-4. PubMed PMID: 32401715; PubMed Central PMCID: PMCPMC7211500.
آمار
تعداد مشاهده مقاله: 2,333
تعداد دریافت فایل اصل مقاله: 1,512


سامانه مدیریت نشریات علمی. قدرت گرفته از سیناوب